Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

Dupilumab helps children with alopecia areata regrow hair safely.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

Dupilumab may help regrow hair in people with severe alopecia.

Tofacitinib effectively promotes hair regrowth in children with alopecia areata, but more research on long-term safety is needed.

Combining triamcinolone acetonide with cryotherapy may reduce scalp hair loss more than using triamcinolone alone.

Ciclosporin can cause excessive hair growth even with testosterone blockers.

Tofacitinib can help hair grow back in alopecia patients but hair loss might return if the dose is lowered.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Upadacitinib successfully treated a child's severe skin and hair loss issues.

Dithranol is more effective than Tacrolimus for hair regrowth in alopecia areata.

Tofacitinib therapy can effectively regrow eyebrows and eyelashes in some alopecia areata patients.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Ritlecitinib is generally safe for adolescents with alopecia areata over 5 years.

The combined therapy of microneedling and light therapy effectively and safely promotes hair regrowth in trichotillomania.

Anifrolumab effectively improved symptoms and reduced steroid use in Japanese patients with systemic lupus erythematosus.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

New medicines that block a specific pathway are showing promise for treating severe hair loss but need more testing for safety and effectiveness.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Topical ruxolitinib may help some skin conditions but needs more research for alopecia areata.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Intradermal testing can better detect corticosteroid allergies than patch testing.

Recombinant Filaggrin-2 microneedles effectively promote hair growth and repair in hair loss.